Schering’s Vicriviroc R&D To Focus On Treatment-Experienced HIV Patients

The decision to focus registration on treatment-experienced patients follows the recent termination of a Phase II trial in treatment-naïve HIV patients.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet